Career Rehabilitation Advances

The verdict may materially improve Sabatini’s ability to raise funding, recruit collaborators, and publish under his own name. His scientific reputation, especially around mTOR biology and cancer metabolism, gives him a plausible route back into major biomedical research.

Each figure is the modeled move of the S&P 500 if the outcome occurs. For information only. Not investment advice.